Global Shrimp Disease Diagnostics Market (2020 to 2025) - Development of DNA-Based Diagnostic Tools such as PCR Presents Opportunites

Dublin, Feb. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Shrimp Disease Diagnostics Market (2020-2025) by Disease, Kit, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Shrimp Disease Diagnostics Market is estimated to be USD 146.8 Mn in 2020 and is expected to reach USD 220.74 Mn by 2025, growing at a CAGR of 8.5%.

Factors such as increasing consumption of shrimp across the globe with the popularity of shrimp farming have led to a high requirement for quality shrimps. This has led to manufacturers focusing on using diagnostic tools for shrimp disease detection, thus enabling the growth of this market. Further, rising collaborations with universities, Government-led organizations, and R&D centers shall propel the growth of this market.

However, factors such as the use of probiotics in aquaculture are hampering the growth of the market.

Market Dynamics

Drivers

• Growing Demand for Shrimp Consumption

• The Popularity of Shrimp Farming in APAC Nations

• Awareness about Concern over the Biotic and Abiotic Condition for Shrimp Farming

• Economic Losses Due to the Viral Outbreak of Shrimp Diseases

Restraints

• Use of Probiotics in Aquaculture

Opportunities

• Technological Advancements in Aquaculture Disease Diagnosis and Detection

• Contract Farming Initiatives and Technological Innovations in Aquaculture

• Development of DNA-Based Diagnostic Tool such as PCR

• Collaborative Market Space with Favorable Government Regulations

Challenges

• Non-Availability of Curative Measures

Trends

• Strengthening Online Presence Through E-Procurement Channels

• Development of 'Multi-Viral' Detection Kits

Segments Covered

By Disease, Yellow Head, or Gill Associated Virus segment is estimated to account as the fast-growing segment during the forecasted period. Since the yellow head virus has been reported to be one of the most pathogenic viruses for cultivated shrimp

By Kit, Assay Based Kit is estimated to account for the fast-growing segment during the forecasted period. It is mainly because of its accurate & reliable results and high throughput time, which can be achieved in a fraction of the time.

By Geography, APAC is anticipated to lead the market. The factors attributing to the growth of this market are majorly due to the high number of farmed shrimp production is from the APAC, which has also exposed the shrimps to increasing shrimp diseases in the South Asian and East Asian nations as compared to the other regions of the world. This has led to manufacturers focusing on cost-effective disease diagnostic kits for quality shrimp production.

The Global Shrimp Disease Diagnostics Market is further segmented based on Disease, Kit, End-User, and Geography.

Company Profiles

Some of the companies covered in this report are Thermo Fisher Scientific, AquaBounty Technologies, Inc., Reagen LLC, GeneReach Biotechnology Corp., Speedy Assay Sdn Bhd, HiMedia Laboratories, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.
Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.
Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market.
Tortoise: Companies that are slow in growth, having a long legacy, and stable or negative in performance.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Shrimp Disease Diagnostics Market.

• The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

• The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.

• The report also contains a competitive analysis using Positioning Quadrants, a Proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market including parent industry

• Important market dynamics and trends

• Market segmentation

• Historical, current, and projected size of the market based on value and volume

• Market shares and strategies of key players

• Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.3 Trends

5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Shrimp Disease Diagnostics Market, By Disease
6.1 Introduction
6.2 Early Mortality Syndrome
6.3 Taura Syndrome Virus
6.4 White Spot Syndrome Virus
6.5 Yellow Head or Gill Associated Virus

7 Global Shrimp Disease Diagnostics Market, By Kit
7.1 Introduction
7.2 Assay Based Kit
7.3 Rapid Testing Kit

8 Global Shrimp Disease Diagnostics Market, By End User
8.1 Introduction
8.2 Aquaculture & Marine Laboratories
8.3 Education & Research Institutes
8.4 Fisheries

9 Global Shrimp Disease Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Spain
9.4.6 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Indonesia
9.5.5 Malaysia
9.5.6 South Korea
9.5.7 Australia
9.5.8 Russia
9.5.9 Rest of APAC
9.6 Rest of the World
9.6.1 Qatar
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 United Arab Emirates

10 Competitive Landscape
10.1 IGR Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Mergers & Acquisitions
10.3.2 Agreements, Collaborations, & Partnerships
10.3.3 New Product Launches & Enhancements
10.3.4 Investments & Fundings

11 Company Profiles
11.1 AquaBounty Technologies, Inc.
11.2 Auro Biotechnologies
11.3 FUJIKURA KASEI CO., LTD
11.4 GeneReach Biotechnology Corp
11.5 HiMedia Laboratories
11.6 Lab - Ind Resource Sdn Bhd.
11.7 REAGEN LLC
11.8 Speedy Assay Sdn Bhd
11.9 SUREBIO
11.10 Thermo Fisher Scientific Inc.

12 Appendix
12.1 Questionnaire

For more information about this report visit https://www.researchandmarkets.com/r/1ndty9

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900